Table 3.
Summary of the TILs that both were differentially expressed in the tumor cells and affected the survival of the patient.
| Groups | Overall Survival (HR *) | Recurrence-Free Survival (HR *) |
|---|---|---|
| HBV−HCC | Plasma cell (1.05) Macrophages M1 (0.95) Dendritic cells activated (1.08) |
T cells CD8 (0.98) Macrophages M0 (1.02) |
| HCV−HCC | Monocytes (1.21) | Neutrophils (1.10) |
| HCC | T cells CD8 (0.97) Dendritic cells activated (1.09) |
Plasma cells (1.05) T cells γ delta (1.04) Monocytes (1.05) Macrophages M0 (1.04) Macrophages M2 (1.02) Dendritic cells activated (1.15) |
* HR: Hazard Ratio.